The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Metformin versus Placebo in Obese Pregnant Women without Diabetes Mellitus
Abstract
BACKGROUND: Obesity is associated with an increased risk of adverse pregnancy outcomes. Lifestyle-intervention studies have not shown improved outcomes. Metformin improves insulin sensitivity and in pregnant patients with gestational diabetes it leads to less weight gain than occurs in those who do not take metformin. METHODS: In this double-blind, placebo-controlled trial, we randomly assigned pregnant women without diabetes who had a body-mass index (BMI; the weight in kilograms divided by the square of the height in meters) of more than 35 to receive metformin, at a dose of 3.0 g per day, or placebo (225 women in each group) from 12 to 18 weeks of gestation until delivery. The BMI was calculated at the time of study entry (12 to 18 weeks of gestation). The primary outcome was a reduction in the median neonatal birth-weight z score by 0.3 SD (equivalent to a 50% reduction, from 20% to 10%, in the incidence of large-for-gestational-age neonates). Secondary outcomes included maternal gestational weight gain and the incidence of gestational diabetes and of preeclampsia, as well as the incidence of adverse neonatal outcomes. Randomization was performed with the use of computer-generated random numbers. The analysis was performed according to the intention-to-treat principle. RESULTS: A total of 50 women withdrew consent during the trial, which left 202 women in the metformin group and 198 in the placebo group. There was no significant between-group difference in the median neonatal birth-weight z score (0.05 in the metformin group [interquartile range, -0.71 to 0.92] and 0.17 in the placebo group [interquartile range, -0.62 to 0.89], P=0.66). The median maternal gestational weight gain was lower in the metformin group than in the placebo group (4.6 kg [interquartile range, 1.3 to 7.2] vs. 6.3 kg [interquartile range, 2.9 to 9.2], P<0.001), as was the incidence of preeclampsia (3.0% vs. 11.3%; odds ratio, 0.24; 95% confidence interval, 0.10 to 0.61; P=0.001). The incidence of side effects was higher in the metformin group than in the placebo group. There were no significant between-group differences in the incidence of gestational diabetes, large-for-gestational-age neonates, or adverse neonatal outcomes. CONCLUSIONS: Among women without diabetes who had a BMI of more than 35, the antenatal administration of metformin reduced maternal weight gain but not neonatal birth weight. (Funded by the Fetal Medicine Foundation; ClinicalTrials.gov number, NCT01273584; EudraCT number, 2008-005892-83.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the Fetal Medicine Foundation trial, almost 80% of women took at least 50% of the total number of tablets prescribed, and 91% of those prescribed more than 2.5 g/day did so(96).”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [96]
In the citing paper
“In the Fetal Medicine Foundation trial, women had a higher BMI (>35 kg/m2 vs. >30 kg/m2), were treated with a higher starting and maximum dose of metformin, and were more compliant than women in the EMPOWaR trial(95, 96).”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [96]
In the citing paper
“Although metformin did not reduce the frequency of LGA neonates, it significantly reduced the frequency of preeclampsia and maternal weight gain, although not the rate of gestational diabetes(96).”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [96]
In the citing paper
“It is also noteworthy that only 13% (443/3329) of eligible patients consented to participate in the EMPOWaR study, whereas 47% (400/844) of eligible women were recruited to the Fetal Medicine Foundation study, making the latter group more representative of women who meet the study’s eligibility criteria and to whom the study’s results apply.”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [96]
In the citing paper
“In the Fetal Medicine Foundation trial, almost 80% of women took at least 50% of the total number of tablets prescribed, and 91% of those prescribed more than 2.5 g/day did so(96).”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [96]
In the citing paper
“Although metformin did not reduce the frequency of LGA neonates, it significantly reduced the frequency of preeclampsia and maternal weight gain, although not the rate of gestational diabetes(96).”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [96]
In the citing paper
“Although metformin did not reduce the frequency of LGA neonates, it significantly reduced the frequency of preeclampsia and maternal weight gain, although not the rate of gestational diabetes(96).”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [96]
In the citing paper
“In the Fetal Medicine Foundation trial, women had a higher BMI (>35 kg/m2 vs. >30 kg/m2), were treated with a higher starting and maximum dose of metformin, and were more compliant than women in the EMPOWaR trial(95, 96).”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [96]
In the citing paper
“Although metformin did not reduce the frequency of LGA neonates, it significantly reduced the frequency of preeclampsia and maternal weight gain, although not the rate of gestational diabetes(96).”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [96]
In the citing paper
“In the Fetal Medicine Foundation trial, women had a higher BMI (>35 kg/m2 vs. >30 kg/m2), were treated with a higher starting and maximum dose of metformin, and were more compliant than women in the EMPOWaR trial(95, 96).”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [96]
Citations
Cites
Ng, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., Mullany, E. C., Biryukov, S., Abbafati, C., Abera, S. F., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60460-8 · Cited by 11,952
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Brown, M. A., Lindheimer, M. D., de Swiet, M., Assche, A. V., & Moutquin, J. (2001) · Hypertension in Pregnancy · doi:10.1081/prg-100104165 · Cited by 1,894
Maternal obesity and pregnancy outcome: a study of 287 213 pregnancies in London
Sebire, N. J., Jolly, M., Harris, J. P., Wadsworth, J., Joffe, M., Beard, R. W., Regan, L., & Robinson, S. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801670 · Cited by 1,740
Brown, M. A., Lindheimer, M. D., de SWIET, M., et al. (2001) · Hypertension in Pregnancy · doi:10.3109/10641950109152635 · Cited by 1,369
Metformin versus insulin for the treatment of gestational diabetes
Rowan, J. A., Hague, W. M., Gao, W., Battin, M. R., & Moore, M. P. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707193 · Cited by 1,291
Yu, Z., Han, S., Zhu, J., Sun, X., Ji, C., & Guo, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061627 · Cited by 851
Catalano, P., & Ehrenberg, H. M. (2006) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2006.00989.x · Cited by 828
Thangaratinam, S., Rogozinska, E., Jolly, K., Glinkowski, S., Roseboom, T., Tomlinson, J. W., Kunz, R., Mol, B. W., Coomarasamy, A., & Khan, K. S. (2012) · BMJ · doi:10.1136/bmj.e2088 · Cited by 802
Poston, L., Bell, R., Croker, H., Flynn, A. C., Godfrey, K. M., Goff, L., Hayes, L., Khazaezadeh, N., Nelson, S. M., Oteng-Ntim, E., et al. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00227-2 · Cited by 642
Flagged first, then by citations
Research works printed but not linked: 1
- Barton JR, 2015, Am J Perinatol, 32, 615
Cited by
Sorted by citations
Stephenson, J., Heslehurst, N., Hall, J., Schoenaker, D. A. J. M., Hutchinson, J., Cade, J. E., Poston, L., Barrett, G., Crozier, S. R., Barker, M., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30311-8 · Cited by 1,222
Influence of Maternal Obesity on the Long-Term Health of Offspring
Godfrey, K. M., Reynolds, R. M., Prescott, S. L., Nyirenda, M., Jaddoe, V. W. V., Eriksson, J. G., & Broekman, B. F. P. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30107-3 · Cited by 1,059
Dimitriadis, E., Rolnik, D. L., Zhou, W., Estrada‐Gutiérrez, G., Koga, K., Francisco, R. P. V., Whitehead, C. L., Hyett, J. A., Costa, F. D. S., Nicolaides, K. H., et al. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00417-6 · Cited by 1,063
Self-citationPreeclampsia—Pathophysiology and Clinical Presentations
Ives, C. W., Sinkey, R. G., Rajapreyar, I. N., Tita, A., & Oparil, S. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.014 · Cited by 934
Parikh, N. I., Gonzalez, J. M., Anderson, C. A. M., Judd, S. E., Rexrode, K. M., Hlatky, M. A., Gunderson, E. P., Stuart, J. J., Vaidya, D., & On behalf of the American Heart Association Council on Epidemiology and Prevention; Council on Arteriosclerosis, T. A. V. B. C. O. C. A. S. N. A. T. S. C. (2021) · Circulation · doi:10.1161/cir.0000000000000961 · Cited by 743
Magee, L. A., Nicolaides, K. H., & von Dadelszen, P. (2022) · New England Journal of Medicine · doi:10.1056/nejmra2109523 · Cited by 613
Self-citationGestational diabetes mellitus: an updated overview
CHIEFARI, E. D., Arcidiacono, B., FOTI, D. P., & Brunetti, A. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0607-5 · Cited by 542
Koletzko, B. V., Godfrey, K. M., Poston, L., Szajewska, H., van Goudoever, J. B., de Waard, M., Brands, B. A., Grivell, R. M., Deussen, A. R., Dodd, J. M., et al. (2019) · Annals of Nutrition and Metabolism · doi:10.1159/000496471 · Cited by 445
Developmental origins of health and disease: current knowledge and potential mechanisms
Hoffman, D. J., Reynolds, R. M., & Hardy, D. B. (2017) · Nutrition Reviews · doi:10.1093/nutrit/nux053 · Cited by 367
Maternal obesity and neurodevelopmental and psychiatric disorders in offspring
Edlow, A. G. (2016) · Prenatal Diagnosis · doi:10.1002/pd.4932 · Cited by 326
Romero, R., Erez, O., Hüttemann, M., Maymon, E., Panaitescu, B., Conde-Agudelo, A., Pacora, P., Yoon, B. H., & Grossman, L. I. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.06.003 · Cited by 253
Developmental origins of NAFLD: a womb with a clue
Wesolowski, S. R., Kasmi, K. C. E., Jonscher, K. R., & Friedman, J. E. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.160 · Cited by 239
Interventions to prevent maternal obesity before conception, during pregnancy, and post partum
Hanson, M. A., Barker, M. E., Dodd, J. M., Kumanyika, S., Norris, S. A., Steegers, E. A. P., Stephenson, J., Thangaratinam, S., & Yang, H. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30108-5 · Cited by 215
Løvvik, T. S., Carlsen, S. M., Salvesen, Ø., Steffensen, B., Bixo, M., Gómez-Real, F., Lønnebotn, M., Hestvold, K. V., Zabielska, R., Hirschberg, A. L., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30002-6 · Cited by 176
A placenta clinic approach to the diagnosis and management of fetal growth restriction
Kingdom, J. C., Audette, M. C., Hobson, S. R., Windrim, R. C., & Morgen, E. K. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.11.575 · Cited by 167
Ma’ayeh, M., & Costantine, M. M. (2020) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2020.101123 · Cited by 197
Inositols: From Established Knowledge to Novel Approaches
Dinicola, S., Unfer, V., Facchinetti, F., Soulage, C. O., Greene, N. D., Bizzarri, M., Laganà, A. S., Chan, S.-Y., Bevilacqua, A., Pkhaladze, L., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910575 · Cited by 154
Aye, I. L. M. H., Aiken, C., Jones, D. S., & Smith, G. C. S. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.11.005 · Cited by 161
The Risks Associated With Obesity in Pregnancy
Stubert, J., Reister, F., Hartmann, S., & Janni, W. J. (2018) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2018.0276 · Cited by 167
Cardiovascular origins of preeclampsia
Kalafat, E., & Thilaganathan, B. (2017) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000419 · Cited by 151
Diabetes in pregnancy: a new decade of challenges ahead
the Diabetic Pregnancy Study Group, Schaefer-Graf, U. M., Napoli, A., & Nolan, C. J. (2018) · Diabetologia · doi:10.1007/s00125-018-4545-y · Cited by 131
Metabolic abnormalities and obesity’s impact on the risk for developing preeclampsia
Spradley, F. T. (2016) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00440.2016 · Cited by 118
Poon, L. C., McIntyre, D. H., Hyett, J. A., da Fonseca, E. B., & Hod, M. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.05.002 · Cited by 124
Risk of pre‐eclampsia in women taking metformin: a systematic review and meta‐analysis
Alqudah, A. M., McKinley, M. C., McNally, R., Graham, U. M., Watson, C. J., Lyons, T. J., & McClements, L. (2017) · Diabetic Medicine · doi:10.1111/dme.13523 · Cited by 117
Gestational diabetes mellitus: does an effective prevention strategy exist?
Agha-Jaffar, R., Oliver, N. S., Johnston, D. G., & Robinson, S. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.88 · Cited by 116
Sex and Gender Differences in Prevention of Type 2 Diabetes
Harreiter, J., & Kautzky‐Willer, A. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00220 · Cited by 127
A cautionary response to SMFM statement: pharmacological treatment of gestational diabetes
Barbour, L. A., Scifres, C., Valent, A. M., Friedman, J. E., Buchanan, T. A., Coustan, D., Aagaard, K., Thornburg, K. L., Catalano, P. M., Galan, H. L., et al. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.06.013 · Cited by 101
Dodd, J., Louise, J., Deussen, A., Grivell, R., Dekker, G., McPhee, A., & Hague, W. (2019) · The Lancet Diabetes and Endocrinology · doi:10.1016/s2213-8587(18)30310-3 · Cited by 96
Vornic, I., Buciu, V. B., Furau, C. G., Gaje, P. N., Ceauşu, R. A., Dumitru, C. Ș., Barb, A. C., Novacescu, D., Cumpănaş, A. A., Latcu, S. C., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212195 · Cited by 121
Long, M., Cai, L., Li, W., Zhang, L., Guo, S., Zhang, R., Zheng, Y., Liu, X., Wang, M., Zhou, X., et al. (2017) · Diabetes · doi:10.2337/db17-0934 · Cited by 98
Guideline No. 391-Pregnancy and Maternal Obesity Part 1: Pre-conception and Prenatal Care
Maxwell, C., Gaudet, L., Cassir, G., Nowik, C., McLeod, N. L., Jacob, C.-É., & Walker, M. (2019) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2019.03.026 · Cited by 96
Tong, S., Kaitu’u‐Lino, T. J., Hastie, R. M., Brownfoot, F., Cluver, C. A., & Hannan, N. J. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.09.014 · Cited by 100
Kalafat, E., Sukur, Y. E., Abdi, A., Thilaganathan, B., & Khalil, A. A. (2018) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.19084 · Cited by 92
Weight gain adequacy and pregnancy outcomes in gestational diabetes: a meta‐analysis
Viecceli, C., Remonti, L. R., Hirakata, V. N., Mastella, L. S., Gnielka, V., Oppermann, M. L. R., Silveiro, S. P., & Reichelt, A. J. (2017) · Obesity Reviews · doi:10.1111/obr.12521 · Cited by 90
Maternal nutrition: opportunities in the prevention of gestational diabetes
Silva‐Zolezzi, I., Samuel, T. M., & Spieldenner, J. (2017) · Nutrition Reviews · doi:10.1093/nutrit/nuw033 · Cited by 92
Attenuating Pregnancy Weight Gain—What Works and Why: A Systematic Review and Meta-Analysis
Walker, R., Bennett, C., Blumfield, M., Gwini, S. M., Ma, J., Wang, F., Wan, Y., & Truby, H. (2018) · Nutrients · doi:10.3390/nu10070944 · Cited by 90
Lin, L., Huai, J., Li, X., Zhu, Y., Juan, J., Zhang, M., Cui, S., Zhao, X., Ma, Y., Zhao, Y., et al. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.08.004 · Cited by 89
Metformin in pregnancy and risk of adverse long-term outcomes: a register-based cohort study
Brand, K. M. G., Saarelainen, L., Sõnajalg, J., Boutmy, E., Foch, C., Vääräsmäki, M., Morin-Papunen, L. C., Schlachter, J., CLUE Study Group, Hakkarainen, K. M., et al. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002363 · Cited by 94
White, S. L., Lawlor, D. A., Briley, A. L., Godfrey, K. M., Nelson, S. M., Oteng‐Ntim, E., Robson, S. C., Sattar, N. A., Seed, P. T., Vieira, M. C., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167846 · Cited by 80
Bennett, C., Walker, R., Blumfield, M., Gwini, S. M., Ma, J., Wang, F., Wan, Y., Dickinson, H., & Truby, H. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.04.010 · Cited by 82
Metformin in Pregnancy: Mechanisms and Clinical Applications
Hyer, S. L., Balani, J., & Shehata, H. A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071954 · Cited by 87
Self-citationADIPS 2020 guideline for pre‐existing diabetes and pregnancy
Rudland, V. L., Price, S., Hughes, R. C. E., Barrett, H. L., Lagstrom, J., Porter, C., Britten, F. L., Glastras, S. J., Fulcher, I., Wein, P., et al. (2020) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.13265 · Cited by 85
Maniar, K., Moideen, A., Mittal, A., Patil, A., Chakrabarti, A., & Banerjee, D. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.12.003 · Cited by 75
Zhang, Y., Liu, W., Zhong, Y., Li, Q., Wu, M., Yang, L., Liu, X., & Zou, L. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/1806344 · Cited by 73
Dodd, J. M., Grivell, R. M., Deussen, A. R., & Hague, W. M. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010564.pub2 · Cited by 74
Metformin from mother to unborn child-are there unwarranted effects?
Nguyen, L., Chan, S.-Y., & Teo, A. K. K. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.08.047 · Cited by 67
Tarry‐Adkins, J. L., Ozanne, S. E., & Aiken, C. (2021) · Scientific Reports · doi:10.1038/s41598-021-88650-5 · Cited by 69
Nzelu, D., Dumitrascu‐Biris, D., Nicolaides, K. H., & Kametas, N. A. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.12.235 · Cited by 72
Self-citationPreeclampsia and the cardiovascular system: An update
Perry, H., Khalil, A. A., & Thilaganathan, B. (2018) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2018.04.009 · Cited by 66
Mills, H. L., Patel, N., White, S. L., Pasupathy, D., Briley, A. L., Ferreira, D. L. S., Seed, P. T., Nelson, S. M., Sattar, N. A., Tilling, K. M., et al. (2019) · BMC Medicine · doi:10.1186/s12916-018-1248-7 · Cited by 65
Bedell, S., Hutson, J. R., de Vrijer, B., & Eastabrook, G. D. M. (2020) · Current Vascular Pharmacology · doi:10.2174/1570161118666200616144512 · Cited by 94
Antidiabetic medication use during pregnancy: an international utilization study
Cesta, C. E., Cohen, J. M., Pazzagli, L., Bateman, B. T., Bröms, G., Einarsdóttir, K., Furu, K., Havard, A., Heino, A., Hernández–Dı́az, S., et al. (2019) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000759 · Cited by 59
Novel Interventions for the Prevention of Preeclampsia
Ma’ayeh, M., Rood, K. M., Kniss, D. A., & Costantine, M. M. (2020) · Current Hypertension Reports · doi:10.1007/s11906-020-1026-8 · Cited by 64
McIntyre, D. H., Kapur, A., Divakar, H., & Hod, M. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.614533 · Cited by 61
Metformin and Vascular Diseases: A Focused Review on Smooth Muscle Cell Function
Deng, M., Su, D., Xu, S., Little, P. J., Feng, X., Tang, L., & Shen, A. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00635 · Cited by 58
Wu, S., Jin, J., Hu, K.-L., Wu, Y., & Zhang, D. (2022) · Nutrients · doi:10.3390/nu14122383 · Cited by 64
Takele, W. W., Vesco, K. K., Josefson, J., Redman, L. M., Hannah, W., Bonham, M. P., Chen, M., Chivers, S. C., Fawcett, A. J., Grieger, J. A., et al. (2024) · Communications Medicine · doi:10.1038/s43856-024-00491-1 · Cited by 55
Metformin: Past, Present, and Future
Chaudhary, S., & Kulkarni, A. (2024) · Current Diabetes Reports · doi:10.1007/s11892-024-01539-1 · Cited by 64
Metabolomic determination of pathogenesis of late-onset preeclampsia
Bahado-Singh, R. O., Syngelaki, A., Mandal, R., Graham, S. F., Akolekar, R., Han, B., Bjondahl, T. C., Dong, E., Bauer, S., Alpay-Savasan, Z., et al. (2016) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2016.1185411 · Cited by 54
Self-citationSantamaria, A., Alibrandi, A., Benedetto, A. D., Pintaudi, B., Corrado, F., Facchinetti, F., & D’Anna, R. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.05.018 · Cited by 57
Recurrent Gestational Diabetes Mellitus: A Narrative Review and Single-Center Experience
Egan, A. M., Enninga, E. A. L., Alrahmani, L., Weaver, A. L., Sarras, M. P., & Ruano, R. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040569 · Cited by 52
Maric‐Bilkan, C., Abrahams, V. M., Arteaga, S. S., Bourjeily, G. R., Conrad, K. P., Catov, J. M., Costantine, M. M., Cox, B., Garovic, V. D., George, E. M., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.11644 · Cited by 56
New Ideas for the Prevention and Treatment of Preeclampsia and Their Molecular Inspirations
Sakowicz, A., Bralewska, M., Rybak-Krzyszkowska, M., Grzesiak, M., & Pietrucha, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512100 · Cited by 51
Kaitu’u‐Lino, T. J., Brownfoot, F., Beard, S., Cannon, P., Hastie, R. M., Nguyen, T. V., Binder, N. K., Tong, S., & Hannan, N. J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0188845 · Cited by 50
Cluver, C. A., Walker, S. P., Mol, B. W., Hall, D. R., Hiscock, R. J., Brownfoot, F., Kaitu’u‐Lino, T. J., & Tong, S. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-025809 · Cited by 48
Fornes, R., Simin, J., Nguyen, M. H., Cruz, G., Crisosto, N., van der Schaaf, M., Engstrand, L., & Brusselaers, N. (2022) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-022-00905-6 · Cited by 44
Liu, Y.-H., Zhang, Y.-S., Chen, J.-Y., Wang, Z., Liu, Y.-X., Li, J., Xu, X.-J., Xie, N., Lye, S. J., Tan, N., et al. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2022.10.014 · Cited by 49
Efficacy and safety of metformin during pregnancy: an update
Paschou, S. Α., Shalit, A., Gerontiti, E., Athanasiadou, K. I., Kalampokas, T., Ψαλτοπούλου, Θ., Lambrinoudaki, I. V., Anastasiou, E., Wolffenbuttel, B. H. R., & Goulis, D. G. (2023) · Endocrine · doi:10.1007/s12020-023-03550-0 · Cited by 49
Fetal Growth and Birth Anthropometrics in Metformin-Exposed Offspring Born to Mothers With PCOS
Hjorth‐Hansen, A. K., Salvesen, Ø. O., Hanem, L. G. E., Eggebø, T. M., Salvesen, K. Å., Vanky, E., & Ødegård, R. A. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01191 · Cited by 49
Syngelaki, A., Campos, M. S., Roberge, S., Andrade, W. S., & Nicolaides, K. H. (2018) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2018.1481037 · Cited by 49
Self-citationMetformin for pregnancy and beyond: the pros and cons
Newman, C., & Dunne, F. (2021) · Diabetic Medicine · doi:10.1111/dme.14700 · Cited by 46
Nutrients in Energy and One-Carbon Metabolism: Learning from Metformin Users
Luciano‐Mateo, F., Hernández‐Aguilera, A., Cabré, N., Camps, J., Fernández‐Arroyo, S., López‐Miranda, J., Menéndez, J. A., & Joven, J. (2017) · Nutrients · doi:10.3390/nu9020121 · Cited by 44
Integrated Proteomic and Metabolomic prediction of Term Preeclampsia
Bahado-Singh, R. O., Poon, L. C., Yılmaz, A., Syngelaki, A., Türkoğlu, O., Kumar, P., Kirma, J., Allos, M., Accurti, V., Li, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-15882-9 · Cited by 45
Self-citationMetformin for non-small cell lung cancer patients: Opportunities and pitfalls
Lévy, A., & Doyen, J. (2018) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.03.001 · Cited by 46
Routy, J., Isnard, S., Mehraj, V., Ostrowski, M., Chomont, N., Ancuța, P., Ponte, R., Planas, D., Dupuy, F. P., & Angel, J. B. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-028444 · Cited by 46
Chatzakis, C., Goulis, D. G., Mareti, Ε., Eleftheriades, M. I., Zavlanos, A., Dinas, K. D., & Sotiriadis, A. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107924 · Cited by 48
Metformin for gestational diabetes mellitus: progeny, perspective, and a personalized approach
Barbour, L. A., & Feig, D. S. (2019) · Diabetes Care · doi:10.2337/dci18-0055 · Cited by 44
Hu, Y. W., Zhou, Y., Yang, Y., Tang, H., Si, Y., Chen, Z., Shi, Y., & Fang, H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.832707 · Cited by 44
Polycystic Ovary Syndrome: Impact of Lipotoxicity on Metabolic and Reproductive Health
Brennan, K. M., Kroener, L. L., Chazenbalk, G. D., & Dumesic, D. A. (2019) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000000661 · Cited by 44
Metformin during Pregnancy: Effects on Offspring Development and Metabolic Function
Jorquera, G., Echiburú, B., Crisosto, N., Sotomayor‐Zárate, R., Maliqueo, M. A., & Cruz, G. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00653 · Cited by 46
Ngene, N. C., & Moodley, J. (2024) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2024.102473 · Cited by 55
Doi, S. A. R., Furuya‐Kanamori, L., Toft, E., Musa, O. A. H., Islam, N., Clark, J., & Thalib, L. (2020) · Obesity Reviews · doi:10.1111/obr.12964 · Cited by 39
Preeclampsia: A comprehensive review
Ali, M., Ahmed, M., Memon, M., Chandio, F., Shaikh, Q., Parveen, A., & Phull, A. R. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.119922 · Cited by 39
Lessons learned from lifestyle prevention trials in gestational diabetes mellitus
Egan, A. M., & Simmons, D. S. (2018) · Diabetic Medicine · doi:10.1111/dme.13772 · Cited by 41
Maternal polycystic ovarian syndrome and early offspring development
Bell, G. A., Sundaram, R., Mumford, S. L., Park, H., Mills, J. L., Bell, E. M., Broadney, M. M., & Yeung, E. H. (2018) · Human Reproduction · doi:10.1093/humrep/dey087 · Cited by 39
Pregestational Diabetes in Pregnancy
Sugrue, R. P., & Zera, C. (2018) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2018.01.002 · Cited by 38
Hufnagel, A., Fernandez‐Twinn, D. S., Blackmore, H. L., Ashmore, T. J., Heaton, R. A., Jenkins, B., Koulman, A., Hargreaves, I. P., Aiken, C., & Ozanne, S. E. (2021) · The Journal of Physiology · doi:10.1113/jp281902 · Cited by 39
Spence, O., Hong, K., Onwuchekwa Uba, R., & Doshi, P. (2020) · Clinical Trials · doi:10.1177/1740774519868310 · Cited by 37
Protective effect of metformin on a rat model of lipopolysaccharide‐induced preeclampsia
Hu, J., Zhang, J., & Zhu, B. (2019) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12501 · Cited by 35
H19 lncRNA alters methylation and expression of Hnf4α in the liver of metformin-exposed fetuses
Deng, J., Mueller, M., Geng, T., Shen, Y., Liu, Y., Hou, P., Ramillapalli, R., Taylor, H. S., Paidas, M. J., & Huang, Y. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.392 · Cited by 35
Gestational diabetes mellitus: Prevention, diagnosis and treatment. A fresh look to a busy corner
Zito, G., Corte, L. D., Giampaolino, P., Terzić, M., Terzic, S., Guardo, F. D., Ricci, G., Pietà, I. D., Maso, G., & Garzon, S. (2019) · Journal of Neonatal-Perinatal Medicine · doi:10.3233/npm-190305 · Cited by 38
Maternal obesity and offspring health: Adapting metabolic changes through autophagy and mitophagy
Wang, L., O’Kane, A., Zhang, Y., & Ren, J. T. (2023) · Obesity Reviews · doi:10.1111/obr.13567 · Cited by 37
Salomäki-Myftari, H., Vähätalo, L. H., Ailanen, L., Pietilä, S., Laiho, A., Hänninen, A., Pursiheimo, J.-P., Munukka, E., Rintala, A., Savontaus, E., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0163805 · Cited by 33
Brownfoot, F., & Rolnik, D. L. (2024) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2024.102481 · Cited by 43
Metformin use in obese mothers is associated with improved cardiovascular profile in the offspring
Παναγιωτοπούλου, Ό., Syngelaki, A., Georgiopoulos, G. A., Simpson, J. M., Akolekar, R., Shehata, H. A., Nicolaides, K. H., & Charakida, M. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.01.054 · Cited by 34
Self-citationFacchinetti, F., Cavalli, P., Copp, A. J., D’Anna, R., Kandaraki, E., Greene, N. D. E., Unfer, V., & for The Experts Group on Inositol in Basic and Clinical Research (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2020.1828344 · Cited by 35
Schoonejans, J. M., Blackmore, H. L., Ashmore, T. J., Aiken, C., Fernandez‐Twinn, D. S., & Ozanne, S. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158104 · Cited by 36
Visceral fat mass as a novel risk factor for predicting gestational diabetes in obese pregnant women
Balani, J., Hyer, S. L., Shehata, H. A., & Mohareb, F. R. (2018) · Obstetric Medicine · doi:10.1177/1753495x17754149 · Cited by 31
Self-citationSimmons, D. S., Devlieger, R., Assche, A. V., Galjaard, S., Corcoy, R., Adelantado, J. M., Dunne, F., Desoyé, G., Kautzky‐Willer, A., Damm, P., et al. (2018) · Nutrients · doi:10.3390/nu10111568 · Cited by 31
Maric, T., Kanu, C., Muller, D. C., Tzoulaki, I., Johnson, M., & Savvidou, M. D. (2020) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.16105 · Cited by 31
Metadata
- Authors
- Syngelaki, A., Nicolaides, K. H., Balani, J., Hyer, S., Akolekar, R., Kotecha, R., Pastides, A., & Shehata, H.
- Affiliations
- Epsom and St Helier University Hospitals NHS Trust (GB)
- Harris Birthright Research Centre for Fetal Medicine (GB)
- St Helier Hospital (GB)
- Medway Maritime Hospital (GB)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2016-02-04
- Volume
- 374
- Issue
- 5
- Pages
- 434-443
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2253351763
- Cited by
- 394
- References
- 33
- Citations by year
- 2026: 17 · 2025: 27 · 2024: 31 · 2023: 25 · 2022: 31 · 2021: 27 · 2020: 39 · 2019: 35 · 2018: 51 · 2017: 90 · 2016: 21
- FWCI
- 84.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Keywords
- metformin, maternal obesity, pregnancy, gestational weight gain, birth weight, large-for-gestational-age neonates, preeclampsia, gestational diabetes mellitus, insulin sensitivity, adverse pregnancy outcomes, placental growth factor, placental protein 13
- MeSH terms
- Adult, Birth Weight, Double-Blind Method, Female, Fetal Macrosomia, Humans, Hypoglycemic Agents, Infant, Newborn, Metformin, Obesity, Pregnancy, Pregnancy Complications, Weight Gain, Body Mass Index, Medication Adherence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
